Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixivaptan in Congestive Heart Failure
NCT01055912Phase 2Completed
- Sponsor
- CardioKine
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Lixivaptan with Placebo (2 arms). Primary endpoint: Efficacy and Safety of Lixivaptan at 8 weeks. Started Jan 2010; status: completed.
02
Drugs
lixivaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01055912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055912.